ALBO - Albireo Pharma Inc
Close
44.15
-0.100 -0.227%
Share volume: 1,241,282
Last Updated: Thu 02 Mar 2023 10:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$44.25
-0.10
-0.23%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | |
Report Date | 2022-05-16 | 2022-08-15 | 2022-11-08 | |
Total revenue | 6.832 M | 8.206 M | 9.832 M | |
Cost of revenue | 234.000 K | 776.000 K | 612.000 K | |
Gross profit | 6.598 M | 7.430 M | 9.220 M | |
12.61% | 24.09% | |||
Operating expenses | 38.758 M | 44.488 M | 43.876 M | |
Selling general and admin | 16.855 M | 21.600 M | 20.564 M | |
Research and development | 21.903 M | 22.888 M | 23.312 M | |
Total expenses | 38.992 M | 45.264 M | 44.488 M | |
16.09% | -1.71% | |||
Operating income | -32.160 M | -37.058 M | -34.656 M | |
Ebit | -32.160 M | -37.058 M | -34.656 M | |
Pretax income | -42.434 M | -39.949 M | -37.800 M | |
-5.86% | -5.38% | |||
Income tax | 0.000 | 0.000 | 0.000 | |
Net income basic | -42.434 M | -39.949 M | -37.800 M | |
5.86% | 5.38% | |||
Net income | -42.434 M | -39.949 M | -37.800 M | |
5.86% | 5.38% |